Business Wire

AMCS Acquires Qv21 Technologies, Strengthening Its Transportation Management Capabilities

4.9.2024 15:00:00 CEST | Business Wire | Press release

Share

Qv21 Technologies’ fleet management and logistics SaaS solutions to support improved waste-to-resource conversion and sustainability for organizations

AMCS, a global leader of sustainability software for foundational industries, announced today its acquisition of Qv21 Technologies, a leading provider of fleet management and logistics SaaS solutions for short-haul, bulk commodity transportation, for an undisclosed amount.

Founded in 2009 in Austin, Texas, Qv21 Technologies enables short-haul and bulk commodity trucking companies of all sizes to increase operational visibility and improve overall efficiency. With their mission of enabling Logistics Without Barriers™, Qv21’s powerful solution, The LogisticsFramework™ (TLF), streamlines business processes from order to invoice. Backed with robust data management, workflow automation, and analytics capabilities, Qv21 ensures organizations are in complete control of their operations while boosting their savings and profit margins.

The innovative fleet management and logistics solutions by Qv21 Technologies, along with its North American footprint and focus on bulk material transportation, are highly complementary to the AMCS Platform, benefiting customers of both organizations. The acquisition empowers AMCS to expand the capabilities of the AMCS Platform, enabling resource-intensive industries to achieve their sustainability goals faster, more efficiently, and profitably.

“Qv21 Technologies has consistently offered innovative solutions built for short-haul, bulk commodity transportation companies, enhancing operational excellence for leading organizations, including those in the waste and recycling sectors,” said Jonathan Currie, CEO, Qv21 Technologies. “Qv21's commitment to 'Logistics Without Barriers' boosts efficiency and profitability for transporters. Beyond the opportunities for business expansion, our partnership with AMCS further strengthens this pursuit of operational excellence for our clients and accelerates our collective vision for greater sustainability.“

This acquisition paves the way for several synergistic opportunities to be realized, specifically aiding organizations in the long-haul transport of bulk commodities that can support a more circular economy vision. Materials that were previously considered waste and destined for landfill sites can now be effectively directed towards reuse or recycling facilities. With Qv21, AMCS can provide organizations with a solution for a more structured, efficient approach to resource utilization and improved waste management, translating to meaningful progress toward their sustainability goals.

“The strategic addition of Qv21 Technologies signifies a crucial advancement for AMCS, reinforcing our position at the forefront of Performance Sustainability,” explained, Jimmy Martin, co-founder and CEO, AMCS. “This partnership provides tremendous opportunities, specifically for companies engaged within bulk material transportation, to reach their sustainability goals faster. The features that Qv21 brings to the table serve to enhance our capabilities at AMCS, strengthening our ability to support our clients' drive towards enhanced resource management, greater efficiency, sustainability, growth, and profitability.”

AMCS’ Performance Sustainability Suite is the operating system for foundational industries that makes sustainability and profitability possible. The suite manages the running of day-to-day operations such as contracts and pricing, logistics and transportation, materials and resources, health and safety, and sustainability intelligence. The AMCS Performance Sustainability Suite drives growth and profitability, optimizes efficiency and safety, powers corporate sustainability initiatives, and prepares businesses for the circular economy and the future. With AMCS, businesses can improve performance and scale more easily, enabling foundational industry professionals to leave the planet in a better way than they found it.

About Qv21 Technologies
Founded in 2009, Qv21 Technologies is an industry-leading SaaS company specializing in Transportation Management Systems for short-haul, bulk commodity transport. Dedicated to building cloud-based tools, Qv21 supports transporters, carriers, and commodity buyers in navigating industry challenges.

Qv21 Technologies’ flagship solution, The LogisticsFramework™ (TLF), increases operational visibility and streamlines business processes, from order to invoice. As a committed technology provider to trucking companies of all sizes, Qv21 makes increasing savings and profit margins achievable, restoring control of operations back to the organization. Learn more at www.qv21.com

About AMCS
At AMCS we are focused on Performance Sustainability – enabling resource-intensive industries to boost sustainability and profitability. Built on decades of experience, our purpose-built software solutions are designed by people who understand your business, providing practical solutions for the resources, waste, recycling, transportation, manufacturing, and utilities industries.

Headquartered in Ireland, and with offices in Europe, the USA, and Australia, AMCS is a global market leader with over 1,300 mission-driven team members. The combined expertise of our team allows AMCS to deliver innovative solutions and extensive insight, helping customers to drive growth and achieve lasting success. As a trusted global partner, we work with 3800 customers in more than 80 countries delivering digital solutions that create meaningful and measurable impact by increasing customer satisfaction, enhancing sustainability, and boosting margins.

At AMCS, we're ready to innovate with you - deploying our experts, processes, and technology to drive your business forward and prepare you for success in a more sustainable, net zero carbon future. Learn more at: www.amcsgroup.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240904279752/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release

If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis

Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release

This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw

Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release

New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra

Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release

Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e

Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 14:41:00 CET | Press release

Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye